Clinical Trial Update: Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating recombinant human C1 esterase inhibitor for acute attacks in hereditary angioedema has completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• Recombinant human C1 inhibitor (C1 esterase inhibitor, recombinant)

Snippet

Sponsor: Pharming Technologies B.V. | Conditions: Hereditary Angioedema, Angioneurotic Edema | Phase 3 | Status: COMPLETED | Results posted: 2012-08-30